Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000055

Sr. VP & Chief Medical Officer gave up 1,540 shares (to pay taxes)

  • Sr. VP & Chief Medical Officer acquired 5,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Adda Nathalie · Sr. VP & Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-15 Exercise or conversion : show line 1 in the form +5,250 28,484 D
2020-12-15 Shares withheld for taxes : show line 2 in the form −1,540 $42.52 $65,481 26,944 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-15 Exercise or conversion : show line 3 in the form Restricted Stock Units −5,250 0 D
Loading xslF345X03/edgar.xml…